Sunovion Pharmaceuticals Inc.
Registered Principal Details
Business Or Interest:
Pharmaceutical manufacturing
Lobbying Interests:
All matters affecting the pharmaceutical and healthcare industry.
CEO Name:
Saburo Hamanaka
Vice President
Pharmaceutical manufacturing
Lobbying Interests:
All matters affecting the pharmaceutical and healthcare industry.
CEO Name:
Saburo Hamanaka
Vice President
Contact
AM
Anthony Magnetti
84 Waterford Drive
Marlborough, MA 01752
(508) 357-7330
(866) 556-8815
tony.magnetti@sunovion.com
http://www.sunovion.com
84 Waterford Drive
Marlborough, MA 01752
(508) 357-7330
(866) 556-8815
tony.magnetti@sunovion.com
http://www.sunovion.com
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|---|---|---|
Nancy McKee | Exclusive Duties N/A | Authorized On 4/11/2011 | Withdrawn On N/A |
Ramie Zelenkova | Exclusive Duties N/A | Authorized On 7/29/2011 | Withdrawn On N/A |
Lobbying Interests
Legislative Bills/Resolutions
September 2011 Special Session Senate Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
10/14/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
Bill Text and History
For
Notification Date10/14/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
Development, drafting or introduction of a proposal relating to
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
LRB-2890/2 related to immunity from liability to drug and device manufacturers and sellers under certain circumstances
Action Intended To Affect
Legislative Matter
Notification Date
10/8/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
10/8/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Academic detailing
Academic detailing
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Health care reform
Health care reform
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicare
Medicare
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Mental health
Mental health
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Open access to mental health drugs
Open access to mental health drugs
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceutical advertising
Pharmaceutical advertising
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceutical companies
Pharmaceutical companies
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceuticals in the environment
Pharmaceuticals in the environment
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Wisconsin Medicaid Preferred Drug List
Wisconsin Medicaid Preferred Drug List
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/28/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2011 January - June $1,937.11 |
2011 July - December $11,004.10 |
2012 January - June $10,111.48 |
2012 July - December $3,128.75 |
Total $26,181.45 |
Total Hours Communicating | 2011 January - June 5.00 |
2011 July - December 7.50 |
2012 January - June 11.00 |
2012 July - December 1.00 |
Total 24.50 |
Total Hours Other | 2011 January - June 4.00 |
2011 July - December 36.00 |
2012 January - June 31.50 |
2012 July - December 12.50 |
Total 84.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December 50% |
2012 January - June |
2012 July - December |
Total 20% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December 10% |
2012 January - June 20% |
2012 July - December 25% |
Total 15% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December 25% |
2012 January - June 20% |
2012 July - December |
Total 18% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December |
2012 January - June 5% |
2012 July - December |
Total 2% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December |
2012 January - June 10% |
2012 July - December 25% |
Total 7% |
2011 January - June |
2011 July - December |
2012 January - June |
2012 July - December |
Total |
---|---|---|---|---|
2011 January - June |
2011 July - December |
2012 January - June 20% |
2012 July - December |
Total 8% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication